Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 43
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 340-348
Open Access | Times Cited: 177
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 116
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses
Shufen Li, Yulan Zhang, Zhenqiong Guan, et al.
Cell Research (2023) Vol. 33, Iss. 3, pp. 201-214
Open Access | Times Cited: 52
Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
Matthew McCallum, Young‐Jun Park, Cameron Stewart, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4231-4245.e13
Open Access | Times Cited: 17
SARS-CoV-2 Drug Resistance and Therapeutic Approaches
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
Judith M. White, Joshua T. Schiffer, Rachel Bender Ignacio, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 58
PCIF1-mediated deposition of 5′-cap N 6 ,2′- O -dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infection
Lingling Wang, Shaobo Wang, Lujing Wu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 5
Open Access | Times Cited: 23
After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives
Hazim O. Khalifa, Yousef Al Ramahi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 739-739
Open Access | Times Cited: 12
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
Jessica Wagoner, Shawn Herring, Tien-Ying Hsiang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 36
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Kunal Nepali, Ram Lal Sharma, Sachin Sharma, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 29
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Aijia Wu, Kunyu Shi, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115923-115923
Closed Access | Times Cited: 17
Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
Matthew McCallum, Young‐Jun Park, Cameron Stewart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells
Miriam Ruth Heindl, Anna-Lena Rupp, Marie Schwerdtner, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 7
Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer
Vivian Truong Jones, Ramona Graves‐Deal, Zheng Cao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 6
DON/DRP‐104 as potent serine protease inhibitors implicated in SARS‐CoV‐2 infection: Comparative binding modes with human TMPRSS2 and novel therapeutic approach
Ernest Oduro‐Kwateng, Mahmoud E. S. Soliman
Journal of Cellular Biochemistry (2024)
Open Access | Times Cited: 6
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals
Jimena Pérez‐Vargas, Gabriel Lemieux, Connor A.H. Thompson, et al.
Antiviral Research (2024) Vol. 225, pp. 105869-105869
Open Access | Times Cited: 6
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Nicola Lott, Caroline E. Gebhard, Susan Bengs, et al.
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 217-231
Open Access | Times Cited: 28
Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review
Andri Frediansyah, Fajar Sofyantoro, Saad Alhumaid, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4305-4305
Open Access | Times Cited: 26
Fusion-Based Deep Learning Architecture for Detecting Drug-Target Binding Affinity Using Target and Drug Sequence and Structure
Kaili Wang, Min Li
IEEE Journal of Biomedical and Health Informatics (2023) Vol. 27, Iss. 12, pp. 6112-6120
Closed Access | Times Cited: 13
Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review
Holly Everest, Phoebe Stevenson-Leggett, Dalan Bailey, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 351-351
Open Access | Times Cited: 22
TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform
Amanda L. Peiffer, Julie M. Garlick, Yujin Wu, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 860-866
Open Access | Times Cited: 11
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19
Adrianus C. M. Boon, Traci L. Bricker, Ethan J. Fritch, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top